Monthly Archives: July 2018

Today’s Research Reports on Trending Tickers: iQIYI and Sogou

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / U.S. markets plunged on Friday, after Twitter reported disappointing second quarter earnings and gross domestic product reflected fairly strong economic growth, however was lower than expected. The Dow Jones Industrial Average fell 0.30 percent to close at 25,451.06, while the S&P 500 Index was down 0.66 percent to close at 2,818.82. The Nasdaq Composite Index dropped 1.46 percent to close at 7,737.42.

“A strong GDP number—and 4.1% is still a good number, even if it was a bit below consensus—will signal that the Fed can continue with its plan for rate increases. That will be top of mind for investors today,” said director of investment management for Huntington Private Bank, Chad Oviatt.

“We remain fairly constructive about equities. Generally speaking there’s a lot of confidence about earnings growth, and the number of firms that are meeting or beating expectations, even in light of names like Facebook,” he added.

RDI Initiates Coverage on:

iQIYI, Inc.
https://rdinvesting.com/news/?ticker=IQ

Sogou Inc.
https://rdinvesting.com/news/?ticker=SOGO

iQIYI’s stock moved 2.66% lower Friday, to close the day at $32.15. The stock recorded a trading volume of 12,424,674 shares, which was below its three months average volume of 23,856,461 shares. In the last year, iQIYI’s shares have traded in a range of 15.30 – 46.23. The share price has gained 110.13% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $34.82 is above its 200-day moving average of $26.22. Shares of iQIYI have fallen roughly 0.46 percent in the past month and are up 106.75 percent year-to-date.

Access RDI’s iQIYI, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IQ

On Friday, shares of Sogou recorded a trading volume of 4,142,643 shares, which was above the three months average volume of 3,377,770 shares. The stock ended the day 4.09% lower at $10.33. The share price has fallen 33.35% from its 52 week high with a 52 week trading range of 7.91 – 15.50. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $11.18 is above its 200-day moving average of $10.18. Shares of the company are trading at a Price to Earnings ratio of 47.60. Shares of Sogou have fallen roughly 9.62 percent in the past month and are down 10.72 percent year-to-date.

Access RDI’s Sogou Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SOGO

Our Actionable Research on iQIYI, Inc. (NASDAQ: IQ) and Sogou Inc. (NYSE: SOGO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507210

Capital Power Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Capital Power Corporation (OTC PINK: CPX) will be discussing their earnings results in their Q2 Earnings Call to be held on July 30, 2018 at 10:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-F64F809BABB67.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 507022

Today’s Research Reports on Cipher Pharmaceuticals, Aurinia Pharmaceuticals, GeneNews and Neovasc

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Cipher Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=CPH.TO

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

GeneNews Limited
https://rdinvesting.com/news/?ticker=GEN.TO

Neovasc Inc.
https://rdinvesting.com/news/?ticker=NVCN.TO

Cipher Pharmaceuticals’ stock had no change Friday, to close the day at $2.76. The stock recorded a trading volume of 200 shares, which was below its three months average volume of 24,337 shares. In the last year, Cipher Pharmaceuticals’ shares have traded in a range of 2.65 – 5.75. The stock is currently trading 52.00% below its 52 week high. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.10 is below its 200-day moving average of $3.89. Shares of Cipher Pharmaceuticals are trading at a Price to Earnings ratio of 11.55. Shares of Cipher Pharmaceuticals have fallen approximately 43.67 percent year-to-date.

Access RDI’s Cipher Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CPH.TO

On Friday, shares of Aurinia Pharmaceuticals recorded a trading volume of 29,504 shares, which was below the three months average volume of 33,287 shares. The stock ended the day 1.06% lower at 7.46. The share price has gained 31.34% from its 52 week low with a 52 week trading range of 5.68 – 9.50. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $7.55 is greater than its 200-day moving average of $7.11. Shares of Aurinia Pharmaceuticals have gained approximately 30.42 percent year-to-date.

Access RDI’s Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

GeneNews’ stock had no change Friday, to close the day at $0.075. The stock recorded a trading volume of 15,000 shares, which was below its three months average volume of 121,565 shares. In the last year, GeneNews’ shares have traded in a range of 0.07 – 0.24. The stock is currently trading 68.75% below its 52 week high. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.08 is below its 200-day moving average of $0.103. Shares of GeneNews have fallen approximately 65.22 percent year-to-date.

Access RDI’s GeneNews Limited Research Report at:
https://rdinvesting.com/news/?ticker=GEN.TO

On Friday, shares of Neovasc recorded a trading volume of 241,058 shares, which was below the three months average volume of 3,248,149 shares. The stock ended the day 5.56% lower at 0.0425. The stock is currently trading 98.17% below its 52 week high with a 52 week trading range of 0.04 – 2.32. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.05 is below its 200-day moving average of $0.2833. Shares of Neovasc have fallen approximately 94.33 percent year-to-date.

Access RDI’s Neovasc Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NVCN.TO

Our Actionable Research on Cipher Pharmaceuticals Inc. (TSX: CPH.TO) and Aurinia Pharmaceuticals Inc. (TSX: AUP.TO) and GeneNews Limited (TSX: GEN.TO) and Neovasc Inc. (TSX: NVCN.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507196

Bryan College Station Chiropractor Opens New Location: Hides In Plain Sight

Bailey Health And Wellness Center announces its new clinic location at 2011 E Villa Maria Rd in Bryan, Texas. The Center continues to offer chiropractic adjustments, spinal decompression, acupuncture, therapeutic massage, injury rehabilitation, and functional medicine testing and treatment.

Bryan, United States – July 30, 2018 /PressCable/

Dr. David N. Bailey, DC, MPH announces his new location in the Bryan College Station area. He now serves patients at 2011 E Villa Maria Rd, inside the office of Renner Chiropractic. This new location of Bailey Health & Wellness Center may be hard to find, but is easily accessible from Texas A&M University, Blinn College, and is in the heart of the healthcare corridor in Bryan, Texas. However, convenience isn’t the only benefit of this new clinic location. The chiropractor and his team are very proud of the place itself, which is larger and is equipped to serve patients better. The clinic continues to offer chiropractic adjustments, spinal decompression, acupuncture, therapeutic massage, injury rehabilitation, and functional medicine testing and treatment.

Dr Bailey said “I’ve been working with Aggieland patients since 1985, and every one I’ve cared for has come with different challenges, I always look forward to helping people find ways to improve their own health and well-being, including finding rapid relief from pain, helping to reach improved nutritional status, gaining better mobility and preventing future injuries and this new location will make it even easier to accomplish these goals, and having more than one doctor on site also benefits patients. Dr. Renner is a joy to work with.”

Dr. Bailey is the only board certified chiropractic orthopedist in the area, and offers medical weight loss and functional medicine laboratory testing and a holistic approach to chronic illnesses. Along with the latest functional medicine healing techniques, clients also can have access to tools to move away from sickness lifestyles and are guided toward rebuilding healthy bodies and healthy lives using wellness habits built on improved nutrition, exercise and alternative healthcare.

People interested in learning more about pain relief, chiropractic care and functional medicine and wellness care are encouraged to contact the clinic. Initial consultations are complimentary. The clinic is in network for nearly all major insurance carriers as well as Medicare. Bailey Health & Wellness Center also can work with your attorney if you are injured and need treatment.

Contact Info:
Name: David N. Bailey, DC, MPH
Organization: Bailey Health And Wellness Center
Address: 2011 E Villa Maria Rd, Bryan, Texas 77802, United States
Phone: +1-979-776-0072

For more information, please visit https://baileyhwc.com

Source: PressCable

Release ID: 384928

Today’s Research Reports on Clairvest Group, Sprott, Pinetree Capital and Gluskin Sheff + Associates

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Clairvest Group Inc.
https://rdinvesting.com/news/?ticker=CVG.TO

Sprott Inc.
https://rdinvesting.com/news/?ticker=SII.TO

Pinetree Capital Ltd.
https://rdinvesting.com/news/?ticker=PNP.TO

Gluskin Sheff + Associates Inc.
https://rdinvesting.com/news/?ticker=GS.TO

Clairvest Group’s stock moved 1.02% lower Friday, to close the day at $49.49. The stock recorded a trading volume of 100 shares, which was below its three months average volume of 411 shares. In the last year, Clairvest Group’s shares have traded in a range of 34.29 – 50.00. The share price has gained 44.33% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $47.38 is greater than its 200-day moving average of $44.93. Shares of the company are trading at a Price to Earnings ratio of 6.07. Shares of Clairvest Group have gained approximately 5.3 percent year-to-date.

Access RDI’s Clairvest Group Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CVG.TO

On Friday, shares of Sprott recorded a trading volume of 240,207 shares, which was above the three months average volume of 187,253 shares. The stock ended the day 1.32% lower at 3.00. The share price has gained 43.54% from its 52 week low with a 52 week trading range of 2.09 – 3.62. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.12 is below its 200-day moving average of $3.13. Shares of Sprott are trading at a Price to Earnings ratio of 18.75. Shares of Sprott have gained approximately 22.95 percent year-to-date.

Access RDI’s Sprott Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SII.TO

Pinetree Capital’s stock moved 1.38% lower Friday, to close the day at $2.15. The stock recorded a trading volume of 623 shares, which was below its three months average volume of 3,387 shares. In the last year, Pinetree Capital’s shares have traded in a range of 1.80 – 3.38. The share price has gained 19.44% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $2.28 is below its 200-day moving average of $2.45. Shares of Pinetree Capital have fallen approximately 17.31 percent year-to-date.

Access RDI’s Pinetree Capital Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=PNP.TO

On Friday, shares of Gluskin Sheff + Associates recorded a trading volume of 134,076 shares, which was above the three months average volume of 86,042 shares. The stock ended the day 1.17% lower at 16.95. The share price has gained 19.79% from its 52 week low with a 52 week trading range of 14.15 – 19.20. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $16.83 is greater than its 200-day moving average of $15.74. Shares of the company are trading at a Price to Earnings ratio of 14.11. Shares of Gluskin Sheff + Associates have gained approximately 1.80 percent year-to-date.

Access RDI’s Gluskin Sheff + Associates Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GS.TO

Our Actionable Research on Clairvest Group Inc. (TSX: CVG.TO) and Sprott Inc. (TSX: SII.TO) and Pinetree Capital Ltd. (TSX: PNP.TO) and Gluskin Sheff + Associates Inc. (TSX: GS.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507197

Today’s Research Reports on Algoma Central, Calfrac Well Services, Air Canada and Gibson Energy

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Algoma Central Corporation
https://rdinvesting.com/news/?ticker=ALC.TO

Calfrac Well Services Ltd.
https://rdinvesting.com/news/?ticker=CFW.TO

Air Canada
https://rdinvesting.com/news/?ticker=AC.TO

Gibson Energy Inc.
https://rdinvesting.com/news/?ticker=GEI.TO

Algoma Central’s stock edged 0.55% higher Friday, to close the day at $14.70. The stock recorded a trading volume of 1,300 shares, which was below its three months average volume of 5,219 shares. In the last year, Algoma Central’s shares have traded in a range of 11.46 – 16.04. The share price has gained 28.27% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $14.96 is below its 200-day moving average of $14.99. Shares of the company are trading at a Price to Earnings ratio of 8.44. Shares of Algoma Central have fallen approximately 8.35 percent year-to-date.

Access RDI’s Algoma Central Corporation Research Report at:
https://rdinvesting.com/news/?ticker=ALC.TO

On Friday, shares of Calfrac Well Services recorded a trading volume of 412,246 shares, which was below the three months average volume of 767,185 shares. The stock ended the day 0.81% higher at 5.00. The share price has gained 55.76% from its 52 week low with a 52 week trading range of 3.21 – 8.35. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $5.64 is below its 200-day moving average of $6.40. Shares of the company are trading at a Price to Earnings ratio of 25.38. Shares of Calfrac Well Services have fallen approximately 16.39 percent year-to-date.

Access RDI’s Calfrac Well Services Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=CFW.TO

Air Canada’s stock edged 0.30% lower Friday, to close the day at $23.41. The stock recorded a trading volume of 2,460,298 shares, which was above its three months average volume of 1,110,639 shares. In the last year, Air Canada’s shares have traded in a range of 19.19 – 29.11. The share price has gained 21.99% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $22.10 is below its 200-day moving average of $24.26. Shares of the company are trading at a Price to Earnings ratio of 3.45. Shares of Air Canada have fallen approximately 9.54 percent year-to-date.

Access RDI’s Air Canada Research Report at:
https://rdinvesting.com/news/?ticker=AC.TO

On Friday, shares of Gibson Energy recorded a trading volume of 596,900 shares, which was above the three months average volume of 271,377 shares. The stock ended the day 0.40% higher at 17.62. The stock is currently trading 9.08% below its 52 week high with a 52 week trading range of 15.68 – 19.38. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $17.52 is greater than its 200-day moving average of $17.22. Shares of Gibson Energy have gained approximately 3.08 percent year-to-date.

Access RDI’s Gibson Energy Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GEI.TO

Our Actionable Research on Algoma Central Corporation (TSX :ALC.TO) and Calfrac Well Services Ltd. (TSX :CFW.TO) and Air Canada (TSX :AC.TO) and Gibson Energy Inc. (TSX :GEI.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507199

Today’s Research Reports on Fortuna Silver Mines, Kirkland Lake Gold, Coro Mining and Aura Minerals

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Fortuna Silver Mines Inc.
https://rdinvesting.com/news/?ticker=FVI.TO

Kirkland Lake Gold Ltd.
https://rdinvesting.com/news/?ticker=KL.TO

Coro Mining Corp.
https://rdinvesting.com/news/?ticker=COP.TO

Aura Minerals Inc.
https://rdinvesting.com/news/?ticker=ORA.TO

Fortuna Silver Mines’ stock moved 1.25% lower Friday, to close the day at $7.13. The stock recorded a trading volume of 259,404 shares, which was below its three months average volume of 366,759 shares. In the last year, Fortuna Silver Mines’ shares have traded in a range of 5.13 – 7.69. The share price has gained 38.99% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $7.27 is greater than its 200-day moving average of $6.65. Shares of the company are trading at a Price to Earnings ratio of 16.98. Shares of Fortuna Silver Mines have gained approximately 8.69 percent year-to-date.

Access RDI’s Fortuna Silver Mines Inc. Research Report at:
https://rdinvesting.com/news/?ticker=FVI.TO

On Friday, shares of Kirkland Lake Gold recorded a trading volume of 508,251 shares, which was below the three months average volume of 611,452 shares. The stock ended the day 0.14% higher at 28.42. The share price has gained 123.96% from its 52 week low with a 52 week trading range of 12.69 – 30.65. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $27.96 is greater than its 200-day moving average of $22.70. Shares of Kirkland Lake Gold are trading at a Price to Earnings ratio of 34.62. Shares of Kirkland Lake Gold have gained approximately 47.48 percent year-to-date.

Access RDI’s Kirkland Lake Gold Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=KL.TO

Coro Mining’s stock had no change Friday, to close the day at $0.10. The stock recorded a trading volume of 12,500 shares, which was below its three months average volume of 168,755 shares. In the last year, Coro Mining’s shares have traded in a range of 0.08 – 0.16. The share price has gained 25.00% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $0.10 is below its 200-day moving average of $0.11. Shares of Coro Mining have fallen approximately 16.67 percent year-to-date.

Access RDI’s Coro Mining Corp. Research Report at:
https://rdinvesting.com/news/?ticker=COP.TO

On Friday, shares of Aura Minerals recorded a trading volume of 40,650 shares, which was above the three months average volume of 10,644 shares. The stock ended the day 1.42% higher at 2.14. The share price has gained 64.62% from its 52 week low with a 52 week trading range of 1.30 – 3.00. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $2.20 is below its 200-day moving average of $2.40. Shares of Aura Minerals Inc. are trading at a Price to Earnings ratio of 2.84. Shares of Aura Minerals have fallen approximately 15.42 percent year-to-date.

Access RDI’s Aura Minerals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ORA.TO

Our Actionable Research on Fortuna Silver Mines Inc. (TSX: FVI.TO) and Kirkland Lake Gold Ltd. (TSX: KL.TO) and Coro Mining Corp. (TSX: COP.TO) and Aura Minerals Inc. (TSX:ORA.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507200

Today’s Research Reports on Stocks to Watch: Twitter and Apple

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / Twitter shares may not have seen the kind of market cap blow that Facebook did after reporting earnings, but nonetheless, the social media stock also plummeted after reporting second quarter results. Twitter’s monthly active user growth was concerning to traders. Shares of Apple also closed in the red as investors prepare for the company’s own earnings report next Tuesday.

RDI Initiates Coverage on:

Twitter, Inc.
https://www.rdinvesting.com/report/?ticker=TWTR

Apple Inc.
https://www.rdinvesting.com/report/?ticker=AAPL

Twitter, Inc. shares collapsed on Friday, closing the day down almost 20.5%. The stock traded explosive volume of 123 million shares compared to an average trading volume of just around 29 million shares. The social media reported earnings that beat on both the top and bottom line but user growth turned negative, sending shares falling. For the second quarter, Twitter reported adjusted net income at $134 million, or 17 cents a share. Analysts had been expecting 16 cents. Revenue saw a growth of 24% to hit $710.5 million, which was also higher than what analysts had been expecting. Monthly user growth fell 1 million to 355 million. Company CFO Ned Segal said the decline in monthly active users of about 3 million was because of the company’s effort to clean up its platform, by purging fake accounts. Before the losses on Friday, shares of the stock had seen gains of roughly 80% so far this year.

Access RDI’s Twitter, Inc. Research Report at:
https://www.rdinvesting.com/report/?ticker=TWTR

Apple Inc. shares were in the red on Friday, closing the day down 1.66% on average trading volume of about 24 million shares. The iPhone maker is expected to report its quarterly earnings on Tuesday, July 31. According to Gorilla Trades strategist, Ken Berman, Apple will likely outperform once it beats estimates. Berman wrote in an email, “I predict an all-around beat, possibly by as much as $1 billion in sales (over $53 billion) and up to seven cents ($2.26) on per-share earnings driven by a heavier mix of higher-priced iPhones, momentum in iPads and strength in services. Apple will be the first company in history to reach this milestone, but others will quickly follow, notably Amazon, then Alphabet, which I forecast will arrive before Microsoft.” According to Bernstein analyst Toni Saccanaghi, “FQ3…results are likely to mean little to investors barring a significant surprise to iPhone units, gross margins, or services trajectory. Investor focus has shifted to iPhone demand in FY19 with the next-generation iPhones.” He also said, “We note that historically, revenue guidance for FY Q4 has *not* been a helpful predictor of the strength of the forthcoming cycle, and FY Q4 gross margin guidance has only been helpful when Apple has guided meaningfully lower.”

Access RDI’s Apple Inc. Research Report at:
https://www.rdinvesting.com/report/?ticker=AAPL

Our Actionable Research on Twitter, Inc. (NYSE: TWTR) and Apple Inc. (NASDAQ: AAPL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507201

Today’s Research Reports on Trending Tickers: Aurora Cannabis and Akorn

NEW YORK, NY / ACCESSWIRE / July 30, 2018 / U.S. markets plunged on Friday, after Twitter reported disappointing second quarter earnings and gross domestic product reflected fairly strong economic growth, however was lower than expected. The Dow Jones Industrial Average fell 0.30 percent to close at 25,451.06, while the S&P 500 Index was down 0.66 percent to close at 2,818.82. The Nasdaq Composite Index dropped 1.46 percent to close at 7,737.42.

“A strong GDP number – and 4.1% is still a good number, even if it was a bit below consensus – will signal that the Fed can continue with its plan for rate increases. That will be top of mind for investors today,” said director of investment management for Huntington Private Bank, Chad Oviatt.

“We remain fairly constructive about equities. Generally speaking there’s a lot of confidence about earnings growth, and the number of firms that are meeting or beating expectations, even in light of names like Facebook,” he added.

RDI Initiates Coverage on:

Aurora Cannabis Inc.
https://rdinvesting.com/news/?ticker=ACBFF

Akorn, Inc.
https://rdinvesting.com/news/?ticker=AKRX

Aurora Cannabis’ stock moved 1.71% higher Friday, to close the day at $5.35. The stock recorded a trading volume of 1,174,930 shares, which was below its three months average volume of 1,768,880 shares. In the last year, Aurora Cannabis’ shares have traded in a range of 1.81 – 12.30. The share price has gained 195.58% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $6.65 is below its 200-day moving average of $7.45. Shares of Aurora Cannabis have fallen roughly 24.33 percent in the past month and are down 29.88 percent year-to-date.

Access RDI’s Aurora Cannabis Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ACBFF

On Friday, shares of Akorn recorded a trading volume of 1,054,677 shares, which was below the three months average volume of 2,824,026 shares. The stock ended the day 3.58% higher at $18.23. The share price has fallen 45.82% from its 52 week high with a 52 week trading range of 10.76 – 33.65. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $16.68 is below its 200-day moving average of $20.10. Shares of Akorn have gained roughly 9.89 percent in the past month and are down 43.44 percent year-to-date.

Access RDI’s Akorn, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AKRX

Our Actionable Research on Aurora Cannabis Inc. (OTCQX: ACBFF) and Akorn, Inc. (NASDAQ: AKRX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507208

Premier Biomedical, Inc. Uplifted to OTCQB

BIEI Trading on OTCQB Effective July 27, 2018

JACKSON CENTER, PA / ACCESSWIRE / July 30, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI) a research based publicly traded biomedical company announced that its stock has begun trading on the OTCQB under the stock symbol BIEI, after several months of trading on OTC as a Pink Sheet stock.

William A. Hartman, President and CEO of Premier Biomedical stated, “This move back to the OTC QB will put us in a more favorable credibility with the trading public and provide upside potential.”

Premier Biomedical is exploring the option of transforming itself into a holding company with four major interrelated technology divisions based around its existing issued and pending patents: 1) PTSD cures, 2) Anti-cancer drugs, 3) Hemp Oil CBD based pain relief products, and 4) Anti-aging treatments.

For more information please contact:
William A. Hartman
President and CEO
Premier Biomedical Inc.
(814) 786-8849
w.hartman@premierbiomedical.com
www.premierbiomedical.com/
www.painreliefmeds.com

About Premier Biomedical, Inc.

Premier Biomedical, Inc. (OTCQB: BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has obtained, via exclusive license agreements, the technology behind three granted US Patents, multiple pending provisional patents. Founded in 2010, Premier has partnered with the University of Texas at El Paso (UTEP). In 2016, the company began developing a line of all-natural pain relief products which they began selling in early 2017 to address the rising opioid addiction problem. The company’s R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. The Company is a fully-reporting issuer whose common stock trades on the OTC marketplace maintained by OTC Markets Group, Inc. under the ticker symbol “BIEI.” For more information please visit our websites: www.premierbiomedical.com/ and www.painreliefmeds.com.

Safe Harbor Notice

Certain statements contained herein are ” forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.

SOURCE: Premier Biomedical, Inc.

ReleaseID: 507147